In:
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 39, No. 1 ( 1995-01), p. 253-255
Abstract:
The penetration of amikacin into the cerebrospinal fluid (CSF) was studied with 16 children (mean age, 1 year and 9 months; range, 4 months to 8 years) with community-acquired bacterial meningitis. Amikacin was given intravenously at a dose of 7.5 mg/kg of body weight twice daily. CSF was collected on day 1, at the expected peak concentration of amikacin in CSF. The mean (standard deviation) concentration of amikacin in CSF was 1.65 (1.6) mg/liter. Concentrations of amikacin in CSF correlated significantly with CSF glucose levels on admission. The mean concentrations of amikacin in CSF were 2.9, 1.1, and 0.20 mg/liter in patients with CSF glucose levels of 〈 1, 1 to 2, and 〉 2 mmol/liter, respectively. Thus, amikacin penetrates the blood-brain barrier substantially in children with bacterial meningitis and achieves particularly high concentrations when CSF glucose level is 〈 1 mmol/liter on admission.
Type of Medium:
Online Resource
ISSN:
0066-4804
,
1098-6596
DOI:
10.1128/AAC.39.1.253
Language:
English
Publisher:
American Society for Microbiology
Publication Date:
1995
detail.hit.zdb_id:
1496156-8
SSG:
12
SSG:
15,3
Permalink
